Grade: Pharmaceutical Grade

Factory Location: Anqing Anhui province

Main Sales Markets: North America,Central/South America,Eastern Europe,Australasia,Middle East,Africa

Monthly Production Capacity: 100kgs per month

Packaging Information: 25kgs per drum

Delivery Lead Time: deliver in two weeks from PO date

Sample Provided: yes

Payment Terms: T/T

Tenofovir alafenamide, also known as TAF and GS-7340, is a nucleotide reverse transcriptase inhibitor (NRTIs) and a novel prodrug of tenofovir. By blocking reverse transcriptase, TAF prevent HIV from multiplying and can reduce the amount of HIV in the body. Tenofovir alafenamide is a prodrug, which means that it is an inactive drug. In the body, tenofovir alafenamide is converted to tenofovir diphosphate (TFV-DP). Tenofovir alafenamide fumarate was approved in November 2015 for treatment of HIV-1.